Design and synthesis of a near-infrared fluorescent nanofiber precursor for detecting cell-secreted urokinase activity

Analytical Biochemistry

Volumn 412, Issue 1, 2011, Pages 26-33

  Malik, Ruchi ^a   Qian, Steven ^a   Law, Benedict ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Nanofiber; Near infrared; Peptide; Urokinase

Indexed keywords

ELECTROPHORESIS; ENZYME ACTIVITY; FLUORESCENCE; NANOFIBERS; PEPTIDES;

DISEASE PROGRESSION; MALIGNANT TRANSFORMATIONS; NEAR INFRARED; NEAR-INFRARED FLUORESCENT; SELF-ASSEMBLED PEPTIDES; UROKINASE; UROKINASE PLASMINOGEN ACTIVATORS (UPA); WESTERN-BLOT ANALYSIS;

INFRARED DEVICES;

NANOFIBER; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; NANOCHEMISTRY; NANOTECHNOLOGY; PRIORITY JOURNAL; SYNTHESIS;

EID: 79952443388     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.01.010     Document Type: Article

References (55)

1. K. Dano, P.A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L.S. Nielsen, and L. Skriver Plasminogen activators, tissue degradation, and cancer Adv. Cancer Res. 44 1985 139 266
2. D.A. Waltz, L.R. Natkin, R.M. Fujita, Y. Wei, and H.A. Chapman Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin J. Clin. Invest. 100 1997 58 67 (Pubitemid 27311243)
3. P. Carmeliet, L. Moons, R. Lijnen, M. Baes, V. Lemaitre, P. Tipping, A. Drew, Y. Eeckhout, S. Shapiro, F. Lupu, and D. Collen Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation Nat. Genet. 17 1997 439 444 (Pubitemid 27518393)
4. G. Jenkins The role of proteases in transforming growth factor-β activation Int. J. Biochem. Cell Biol. 40 2008 1068 1078
5. M.J. Duffy, T.M. Maguire, E.W. McDermott, and N. O'Higgins Urokinase plasminogen activator: a prognostic marker in multiple types of cancer J. Surg. Oncol. 71 1999 130 135 (Pubitemid 29288493)
6. M.J. Duffy, C. Duggan, H.E. Mulcahy, E.W. McDermott, and N.J. O'Higgins Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease Clin. Chem. 44 1998 1177 1183 (Pubitemid 28283054)
7. S.F. Shariat, C.G. Roehrborn, J.D. McConnell, S. Park, N. Alam, T.M. Wheeler, and K.M. Slawin Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis J. Clin. Oncol. 25 2007 349 355 (Pubitemid 350002982)
8. R. Swiercz, J.D. Wolfe, A. Zaher, and J. Jankun Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype Clin. Cancer Res. 4 1998 869 877 (Pubitemid 28183387)
9. W. Kuhn, B. Schmalfeldt, U. Reuning, L. Pache, U. Berger, K. Ulm, N. Harbeck, K. Spathe, P. Dettmar, H. Hofler, F. Janicke, M. Schmitt, and H. Graeff Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc Br. J. Cancer 79 1999 1746 1751 (Pubitemid 29132299)
10. H. Kobayashi, S. Fujishiro, and T. Terao Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus Cancer Res. 54 1994 6539 6548
11. S.R. Harvey, T.C. Hurd, G. Markus, M.I. Martinick, R.M. Penetrante, D. Tan, P. Venkataraman, N. DeSouza, S.N. Sait, D.L. Driscoll, and J.F. Gibbs Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer Clin. Cancer Res. 9 2003 4935 4943 (Pubitemid 37323300)
12. D.W. Hsu, J.T. Efird, and E.T. Hedley-Whyte Prognostic role of urokinase-type plasminogen activator in human gliomas Am. J. Pathol. 147 1995 114 123
13. M.M. Skelly, A. Troy, M.J. Duffy, H.E. Mulcahy, C. Duggan, T.G. Connell, D.P. O'Donoghue, and K. Sheahan Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome Clin. Cancer Res. 3 1997 1837 1840 (Pubitemid 27444725)
14. H. Nekarda, M. Schmitt, K. Ulm, A. Wenninger, H. Vogelsang, K. Becker, J.D. Roder, U. Fink, and J.R. Siewert Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer Cancer Res. 54 1994 2900 2907 (Pubitemid 24187770)
15. F. Janicke, A. Prechtl, C. Thomssen, N. Harbeck, C. Meisner, M. Untch, C.G. Sweep, H.K. Selbmann, H. Graeff, and M. Schmitt Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 J. Natl. Cancer Inst. 93 2001 913 920 (Pubitemid 32624648)
16. K. Annecke, M. Schmitt, U. Euler, M. Zerm, D. Paepke, S. Paepke, G. von Minckwitz, C. Thomssen, and N. Harbeck UPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial Adv. Clin. Chem. 45 2008 31 45
17. M.P. Look, W.L. van Putten, M.J. Duffy, N. Harbeck, I.J. Christensen, C. Thomssen, R. Kates, F. Spyratos, M. Ferno, and S. Eppenberger-Castori Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients J. Natl. Cancer Inst. 94 2002 116 128 (Pubitemid 34121291)
18. M. Schmitt, A.S. Sturmheit, A. Welk, C. Schnelldorfer, and N. Harbeck Procedures for the quantitative protein determination of urokinase and its inhibitor, PAI-1, in human breast cancer tissue extracts by ELISA Methods Mol. Med. 120 2006 245 265
19. T.J. Benraad, J. Geurts-Moespot, J. Grondahl-Hansen, M. Schmitt, J.J. Heuvel, J.H. de Witte, J.A. Foekens, R.E. Leake, N. Brunner, and C.G. Sweep Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshop Eur. J. Cancer A 32 1996 1371 1381
20. E. Dublin, A. Hanby, N.K. Patel, R. Liebman, and D. Barnes Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma: fibroblastic expression has strong associations with tumor pathology Am. J. Pathol. 157 2000 1219 1227
21. N. Harbeck, R.E. Kates, M.P. Look, M.E. Meijer-Van Gelder, J.G. Klijn, A. Kruger, M. Kiechle, F. Janicke, M. Schmitt, and J.A. Foekens Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424) Cancer Res. 62 2002 4617 4622
22. N. Harbeck, P. Dettmar, C. Thomssen, U. Berger, K. Ulm, R. Kates, H. Hofler, F. Janicke, H. Graeff, and M. Schmitt Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: six-year median follow-up Br. J. Cancer 80 1999 419 426 (Pubitemid 29213195)
23. K. Chockalingam, M. Blenner, and S. Banta Design and application of stimulus-responsive peptide systems Protein Eng. Des. Sel. 20 2007 155 161 (Pubitemid 351321297)
24. S. Zhang, D.M. Marini, W. Hwang, and S. Santoso Design of nanostructured biological materials through self-assembly of peptides and proteins Curr. Opin. Chem. Biol. 6 2002 865 871 (Pubitemid 35449349)
25. S. Zhang, F. Gelain, and X. Zhao Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures Semin. Cancer Biol. 15 2005 413 420 (Pubitemid 41140309)
26. V.F. Segers, and R.T. Lee Local delivery of proteins and the use of self-assembling peptides Drug Discov. Today 12 2007 561 568 (Pubitemid 47031660)
27. B. Law, R. Weissleder, and C.H. Tung Protease-sensitive fluorescent nanofibers Bioconjug. Chem. 18 2007 1701 1704 (Pubitemid 350219964)
28. R. Weissleder, and M.J. Pittet Imaging in the era of molecular oncology Nature 452 2008 580 589 (Pubitemid 351483372)
29. J. Kisiday, M. Jin, B. Kurz, H. Hung, C. Semino, S. Zhang, and A.J. Grodzinsky Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair Proc. Natl. Acad. Sci. USA 99 2002 9996 10001 (Pubitemid 34831161)
30. J.D. Kisiday, P.W. Kopesky, C.H. Evans, A.J. Grodzinsky, C.W. McIlwraith, and D.D. Frisbie Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures J. Orthop. Res. 26 2008 322 331
31. S.H. Ke, G.S. Coombs, K. Tachias, D.R. Corey, and E.L. Madison Optimal subsite occupancy and design of a selective inhibitor of urokinase J. Biol. Chem. 272 1997 20456 20462 (Pubitemid 27355599)
32. R.C. Bergstrom, G.S. Coombs, S. Ye, E.L. Madison, E.J. Goldsmith, and D.R. Corey Binding of nonphysiological protein and peptide substrates to proteases: differences between urokinase-type plasminogen activator and trypsin and contributions to the evolution of regulated proteolysis Biochemistry 42 2003 5395 5402 (Pubitemid 36560436)
33. B. Law, A. Curino, T.H. Bugge, R. Weissleder, and C.H. Tung Design, synthesis, and characterization of urokinase plasminogen-activator-sensitive near-infrared reporter Chem. Biol. 11 2004 99 106 (Pubitemid 38203994)
34. A.J. Mank, and E.S. Yeung Diode laser-induced fluorescence detection in capillary electrophoresis after pre-column derivatization of amino acids and small peptides J. Chromatogr. A 708 1995 309 321
35. R.B. Mujumdar, L.A. Ernst, S.R. Mujumdar, C.J. Lewis, and A.S. Waggoner Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters Bioconjug. Chem. 4 1993 105 111
36. L. Ruan, H. Zhang, H. Luo, J. Liu, F. Tang, Y.K. Shi, and X. Zhao Designed amphiphilic peptide forms stable nanoweb, slowly releases encapsulated hydrophobic drug, and accelerates animal hemostasis Proc. Natl. Acad. Sci. USA 106 2009 5105 5110
37. B. Law, and C.H. Tung Structural modification of protease inducible preprogrammed nanofiber precursor Biomacromolecules 9 2008 421 425 (Pubitemid 351298458)
38. B. Law, and C.H. Tung Proteolysis: a biological process adapted in drug delivery, therapy, and imaging Bioconjug. Chem. 20 2009 1683 1695
39. J.K. Kim, J. Anderson, H.W. Jun, M.A. Repka, and S. Jo Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery Mol. Pharm. 6 2009 978 985
40. J.M. Atkinson, C.S. Siller, and J.H. Gill Tumour endoproteases: the cutting edge of cancer drug delivery? Br. J. Pharmacol. 153 2008 1344 1352 (Pubitemid 351481504)
41. Y. Chau, R.F. Padera, N.M. Dang, and R. Langer Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models Int. J. Cancer 118 2006 1519 1526
42. M. Rooseboom, J.N. Commandeur, and N.P. Vermeulen Enzyme-catalyzed activation of anticancer prodrugs Pharmacol. Rev. 56 2004 53 102 (Pubitemid 38314580)
43. J.R. Tauro, B.S. Lee, S.S. Lateef, and R.A. Gemeinhart Matrix metalloprotease selective peptide substrates cleavage within hydrogel matrices for cancer chemotherapy activation Peptides 29 2008 1965 1973
44. W. Pham, Y. Choi, R. Weissleder, and C.H. Tung Developing a peptide-based near-infrared molecular probe for protease sensing Bioconjug. Chem. 15 2004 1403 1407 (Pubitemid 39552031)
45. S. Koutsopoulos, L.D. Unsworth, Y. Nagai, and S. Zhang Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold Proc. Natl. Acad. Sci. USA 106 2009 4623 4628
46. J.R. Westphal, R. Van't Hullenaar, A. Geurts-Moespot, F.C. Sweep, J.H. Verheijen, M.M. Bussemakers, J. Askaa, I. Clemmensen, A.A. Eggermont, D.J. Ruiter, and R.M. De Waal Angiostatin generation by human tumor cell lines: involvement of plasminogen activators Int. J. Cancer 86 2000 760 767 (Pubitemid 30350189)
47. R. Weissleder, C.H. Tung, U. Mahmood, and A. Bogdanov Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes Nat. Biotechnol. 17 1999 375 378 (Pubitemid 29166041)
48. J. Banerjee, A.J. Hanson, B. Gadam, A.I. Elegbede, S. Tobwala, B. Ganguly, A.V. Wagh, W.W. Muhonen, B. Law, J.B. Shabb, D.K. Srivastava, and S. Mallik Release of liposomal contents by cell-secreted matrix metalloproteinase-9 Bioconjug. Chem. 20 2009 1332 1339
49. S. Lee, J.H. Ryu, K. Park, A. Lee, S.Y. Lee, I.C. Youn, C.H. Ahn, S.M. Yoon, S.J. Myung, D.H. Moon, X. Chen, K. Choi, I.C. Kwon, and K. Kim Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo Nano Lett. 9 2009 4412 4416
50. S. Lee, K. Park, K. Kim, K. Choi, and I.C. Kwon Activatable imaging probes with amplified fluorescent signals Chem. Commun. 36 2008 4250 4260
51. X. Zhao, and S. Zhang Designer self-assembling peptide materials Macromol. Biosci. 7 2007 13 22 (Pubitemid 46191956)
52. J. Sun, and Q. Zheng Experimental study on self-assembly of KLD-12 peptide hydrogel and 3-D culture of MSC encapsulated within hydrogel in vitro J. Huazhong Univ. Sci. Technol. Med. Sci. 29 2009 512 516
53. S. Zhang Fabrication of novel biomaterials through molecular self-assembly Nat. Biotechnol. 21 2003 1171 1178 (Pubitemid 37186173)
54. M.J. Duffy Proteases as prognostic markers in cancer Clin. Cancer Res. 2 1996 613 618 (Pubitemid 26133464)
55. M.J. Duffy, and J. Crown A personalized approach to cancer treatment: how biomarkers can help Clin. Chem. 54 2008 1770 1779